Development of a brief diabetes distress screening instrument

Authors: Lawrence Fisher, Russell E Glasgow, Joseph T Mullan, Marilyn M Skaff, William H Polonsky

Abstract

Purpose: Previous research has documented that diabetes distress, defined as patient concerns about disease management, support, emotional burden, and access to care, is an important condition distinct from depression. We wanted to develop a brief diabetes distress screen instrument for use in clinical settings.

Methods: We assessed 496 community-based patients with type 2 diabetes on the previously validated, 17-item Diabetes Distress Scale (DDS17) and 6 biobehavioral measures: glycated hemoglobin (HbA(1c)); non-high-density-lipoprotein (non-HDL) cholesterol; kilocalories, percentage of calories from fat, and number of fruit and vegetable servings consumed per day; and physical activity as measured by the International Physical Activity Questionnaire.

Results: An average item score of > or =3 (moderate distress) discriminated high- from low-distressed subgroups. The 4 DDS17 items with the highest correlations with the DDS17 total (r = .56-.61) were selected. Composites, comprised of 2, 3, and 4 of these items (DDS2, DDS3, DDS4), yielded higher correlations (r=.69-.71). The sensitivity and specificity of the composites were .95 and .85, .93 and .87, and .97 and .86, respectively. The DDS3 had a lower sensitivity and higher percentages of false-negative and false-positive results. All 3 composites significantly discriminated subgroups on HbA(1c), non-HDL cholesterol, and kilocalories consumed per day; none discriminated subgroups on fruit and vegetable servings consumed per day; and only the DDS3 yielded significant results on the International Physical Activity Questionnaire. Because of its psychometric properties and brevity, the DDS2 was selected as a screening instrument.

Conclusions: The DDS2 is a 2-item diabetes distress screening instrument asking respondents to rate on a 6-point scale the degree to which the following items caused distress: (1) feeling overwhelmed by the demands of living with diabetes, and (2) feeling that I am often failing with my diabetes regimen. The DDS17 can be administered to those who have positive findings on the DDS2 to define the content of distress and to direct intervention.

Source: https://pubmed.ncbi.nlm.nih.gov/18474888/

Share the Post:

BDI Monthly Events

November 11
November 11Case Consultation
November 11: BDI hosts the San Diego-wide, monthly case consultation meeting (for mental health professionals working in the field of diabetes). Contact us at info@behavioraldiabetes.org if you are in the greater San Diego area and would like further information about this program.
November 14
November 14World Diabetes Day!
November 14: World Diabetes Day! Time for another T1D meet-up! GrownupT1Ds, a wonderful nonprofit that organizes fun social events for adults with type 1 diabetes here in southern California and now spreading to other cities across the United States. The next local one will be at Brewery X, 3191 E. La Palma Ave., Anaheim, CA 92806. Things get started at 2:00 P.M. Please RSVP at kelly@grownup.t1ds.org
November 26
November 26Happy Thanksgiving!
This Thanksgiving, we are especially grateful for the individuals, families, healthcare professionals, and friends who make up the BDI community. Thank you for your continued support and for sharing in our mission to improve the emotional well-being of people living with diabetes. Wishing you and your loved ones a warm and happy Thanksgiving!
November 3
November 3Engaging the Disengaged
November 3: Dr. Polonsky (BDI President) will be speaking on “Engaging the Disengaged: Diabetes Distress, Diabetes Burnout and More” at the Southern California Permanente Medical Group’s 32th Annual Diabetes Hybrid Symposium, in Long Beach (CA).